Skip to main content
Equibles

STATE STREET CORP

Position in GLSI — Greenwich LifeSciences, Inc.

CIK 93751 BOSTON, MA
Back to GLSI Full portfolio

Position in GLSI

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$3,356,797
+$141,120 QoQ
Shares Held
143,086
+6.9% QoQ
Ownership
0.975%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 57 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 26% Shared 0% None 74%

Common Shares in GLSI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. GLSI ranks #242 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in GLSI

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,356,797 143,086
2026-03-31 $3,215,677 133,875
2025-12-31 $2,054,294 97,777
2025-09-30 $815,362 81,946
2025-06-30 $745,980 82,247
2025-03-31 $717,484 75,208
2024-12-31 $822,125 73,208
2024-09-30 $1,026,132 71,408
2024-06-30 $1,180,635 68,403
2024-03-31 $259,259 13,002
2023-12-31 $136,781 13,002
2023-09-30 $114,937 13,002
2023-06-30 $125,404 13,002
2023-03-31 $179,297 13,002
2022-12-31 $197,630 13,002
2022-09-30 $118,318 13,002
2022-06-30 $110,126 13,002
2022-03-31 $1,304,435 66,485
2021-12-31 $1,588,967 65,309
2021-09-30 $2,333,025 59,714
2021-06-30 $2,256,527 50,212